Nabumetone
- Product NDC
- 49884-650
- 11-digit product format
- 498840650
- Labeler code
- 49884
- Product ID
- 49884-650_8a87dcd6-883f-486e-8f4a-8ff1e6080140
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Par Pharmaceutical Inc
- Application
- ANDA076009
- Marketing category
- ANDA
- Marketing start
- 2003-01-24
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9d4d18c4-d38e-37e1-df1c-ee38762bf8a5 | Product name | 4 | 20251024 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49884-650-01 | 2025-02-05 | C162847 | 48780-1 | 9d75b9d1-27e4-f424-e053-dadaa90a57ce | fcbc1d42-a883-435a-a8a8-e12c308a87d8 |
| 49884-650-05 | 2025-02-05 | C162847 | 48780-1 | 9d75b9d1-27e4-f424-e053-dadaa90a57ce | fcbc1d42-a883-435a-a8a8-e12c308a87d8 |
| 49884-650-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-27e4-f424-e053-dadaa90a57ce | fcbc1d42-a883-435a-a8a8-e12c308a87d8 |
| 49884-650-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-27e4-f424-e053-dadaa90a57ce | fcbc1d42-a883-435a-a8a8-e12c308a87d8 |
DailyMed Socrata Ingredients#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311893 | nabumetone 750 MG Oral Tablet | PSN | 8fa594c9-75f3-474b-bba3-b8110bafb82c | 1 |
| 311893 | nabumetone 750 MG Oral Tablet | SCD | 8fa594c9-75f3-474b-bba3-b8110bafb82c | 1 |